Colgate-Palmolive Company $CL Shares Bought by KPP Advisory Services LLC

KPP Advisory Services LLC boosted its stake in Colgate-Palmolive Company (NYSE:CL) by 12.3% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 11,816 shares of the company’s stock after acquiring an additional 1,293 shares during the quarter. KPP Advisory Services LLC’s holdings in Colgate-Palmolive were worth $1,074,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Brighton Jones LLC raised its position in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after purchasing an additional 450 shares during the last quarter. Procyon Advisors LLC boosted its stake in shares of Colgate-Palmolive by 225.9% in the first quarter. Procyon Advisors LLC now owns 13,566 shares of the company’s stock worth $1,271,000 after acquiring an additional 9,403 shares during the last quarter. Congress Asset Management Co. increased its position in shares of Colgate-Palmolive by 7.0% during the first quarter. Congress Asset Management Co. now owns 160,133 shares of the company’s stock worth $15,004,000 after purchasing an additional 10,414 shares in the last quarter. Gateway Investment Advisers LLC raised its stake in Colgate-Palmolive by 18.7% in the 1st quarter. Gateway Investment Advisers LLC now owns 14,085 shares of the company’s stock valued at $1,320,000 after purchasing an additional 2,221 shares during the last quarter. Finally, Miracle Mile Advisors LLC lifted its holdings in Colgate-Palmolive by 3.5% in the 1st quarter. Miracle Mile Advisors LLC now owns 12,651 shares of the company’s stock valued at $1,185,000 after purchasing an additional 429 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Down 0.4%

Shares of CL opened at $78.01 on Monday. The company’s 50-day simple moving average is $83.29 and its 200-day simple moving average is $88.30. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. Colgate-Palmolive Company has a 1 year low of $77.91 and a 1 year high of $102.61. The stock has a market capitalization of $63.05 billion, a PE ratio of 21.91, a P/E/G ratio of 4.06 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.03. The firm had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm’s revenue for the quarter was up 1.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.91 EPS. Analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive’s payout ratio is presently 58.43%.

Analyst Ratings Changes

CL has been the subject of several research reports. Wells Fargo & Company dropped their price objective on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a research note on Thursday, September 25th. JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating for the company in a report on Monday, August 4th. The Goldman Sachs Group lowered their price target on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research report on Thursday. Morgan Stanley reduced their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Finally, Citigroup cut their price target on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a report on Monday, August 4th. Seven analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $94.83.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.